日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of a Newly Developed Botulinum Toxin A (MBA-P01) in Patients with Moderate-to-Severe Glabellar Lines: A Randomized, Double-Blind, Active-Controlled, Multi-Center, Phase III Study with a Subgroup Analysis on Patients with COVID-19

一项针对中重度眉间纹患者的随机、双盲、阳性对照、多中心III期研究,并对COVID-19患者进行了亚组分析,旨在评估新研发的A型肉毒杆菌毒素(MBA-P01)的疗效和安全性。

Han, Hye Sung; Kim, Won-Serk; Lee, Yangwon; Won, Chong-Hyun; Lee, Wooshun; Choi, Sun Young; Kim, Beom Joon

Development and Validation of Photonumeric Scales for Glabellar, Lateral Canthal, and Forehead Lines

眉间纹、外眦纹和额纹的光度数字评分系统的开发与验证

Lorenc, Z Paul; Smith, Stacy; Bass, Lawrence S; Bloom, Jason D; Downie, Jeanine; Jones, Derek; Moradi, Amir; Lee, Wooshun; Go, Seolhui

Development and Validation of Facial Line Distress Scale for Forehead Lines: FINE-FL

额纹面部皱纹困扰量表(FINE-FL)的开发与验证

Kang, Eunjee; Kang, Danbee; Kim, Sooyeon; Choi, Kyeongrok; Lee, Wooshun; Cho, Juhee